Evidence map›Paper›PMID 41083945›Full record

ArticleBMC infectious diseases2025

Disruptions of healthcare visits and viral suppression for people living with HIV during the COVID-19 pandemic in the US.

Xueying Yang, Ruilie Cai, Buwei He, Sharon Weissman, Bankole Olatosi, Xiaoming Li, Jiajia Zhang

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xueying YangDepartment of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA. xueyyang@mailbox.sc.edu.
Ruilie CaiSouth Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.
Buwei HeSouth Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.
Sharon WeissmanSouth Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.
Bankole OlatosiSouth Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.
Xiaoming LiDepartment of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.
Jiajia ZhangSouth Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA.

Funding

Patterns and predictors of viral suppression: A Big Data approachR01AI164947 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI OLATOSI, BANKOLE, ZHANG, JIAJIA · 2021 to 2025
$4.4M
The COVID-19 vaccine efficacy among people living with and without HIV: a real-world data approachR21AI170159 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI YANG, XUEYING · 2022 to 2023
$398k
NIAID NIH HHS R01 AI164947NIAID NIH HHS R21 AI170159NIH HHS R01AI164947-02S1NIH HHS R21AI170159-01A1
6 · The paper itself

Abstract

backgroundExisting studies have documented the negative impact of the COVID-19 pandemic on the utilization of health services among people living with HIV (PLWH), including reduced access to medical consultations, antiretroviral therapy (ART) uptake, and viral load monitoring. However, few studies have investigated the pandemic’s effect on clinical outcomes—such as viral suppression rates—particularly within U.S. settings. Using a nationwide data source, this study aims to examine the impact of the COVID-19 pandemic on healthcare visits and viral suppression outcomes of PLWH.

methodsThis retrospective cohort study used data from All of Us (AoU) Research Program, a nationwide cohort designed to be broadly representative of the U.S. population, particularly groups historically underrepresented in biomedical research. Data from more than 340 sites, deposited into AoU and harmonized into a release set spanning January 2018 through December 2021, were used for this study. Using CD4 count or viral load measures as proxies for health care visits, we employed generalized linear mixed regression interrupted time series (ITS) models with a log link to assess the impact of the COVID-19 pandemic on the number of healthcare visits and viral suppressions, comparing data two years before and after the onset of the pandemic. Among 7,667 PLWH identified, 1,772 who had at least one CD4 count or viral load measure were included in the healthcare visit analysis, and 1,382 who had at least one viral load measure were included in the viral suppression analysis.

resultsFor the outcomes of interest, the total number of healthcare visits dropped from 7,902 (average of 4.90 per person) before pandemic to 5,252 (average of 3.70 per person) after the pandemic. Similarly, the total number of viral suppression events declined from 2,361 (average of 1.98 per person) before pandemic to 1,893 (average of 1.88 per person) after pandemic. Compared to the pre-COVID-19 period, the number of healthcare visits among PLWH significantly decreased (adjusted odds ratio [aOR] = 0.80, 95%CI: 0.75–0.86) whereas the number of viral suppression events did not change significantly (aOR = 1.10, 95%CI: 0.97–1.25) after the pandemic. Older individuals had lower odds of healthcare visits, while those with Medicaid insurance and individuals with more comorbidities were more likely to have healthcare visits. Regarding viral suppression, older individuals, Hispanic or Latino participants, and those who were married or living with partners were more likely to achieve viral suppression, whereas individuals with a greater number of comorbidities were less likely to achieve viral suppression.

conclusionsThe COVID-19 pandemic disrupted healthcare visits and contributed to suboptimal viral suppression among underrepresented HIV populations. Targeted interventions are needed to ensure continuous engagement in HIV care during unprecedented health crises.

Indexed as

COVID-19HIV InfectionsPatient Acceptance of Health CareAdultCD4 Lymphocyte CountFemaleHumansMaleMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2United StatesViral LoadCOVID-19HIV/AIDSService interruptionViral suppression

Identifiers

PMID41083945
PMCPMC12519829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.